Virtu Financial’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-15,837
| Closed | -$640K | – | 1964 |
|
|
2025
Q3 | $640K | Sell |
15,837
-10,155
| -39% | -$588K | 0.04% | 464 |
|
|
2025
Q2 | $1.94M | Sell |
25,992
-80,327
| -76% | -$7.1M | 0.1% | 180 |
|
|
2025
Q1 | $10M | Sell |
106,319
-23,725
| -18% | -$1.74M | 0.55% | 16 |
|
|
2024
Q4 | $9.43M | Buy |
130,044
+74,379
| +134% | +$4.55M | 0.5% | 21 |
|
|
2024
Q3 | $3.25M | Sell |
55,665
-29,252
| -34% | -$1.78M | 0.18% | 78 |
|
|
2024
Q2 | $6.22M | Buy |
84,917
+44,753
| +111% | +$3.78M | 0.43% | 33 |
|
|
2024
Q1 | $2.93M | Sell |
40,164
-27,115
| -40% | -$2.26M | 0.22% | 76 |
|
|
2023
Q4 | $6.52M | Buy |
67,279
+2,904
| +5% | +$565K | 0.52% | 18 |
|
|
2023
Q3 | $13.3M | Buy |
64,375
+10,833
| +20% | +$1.76M | 1.32% | 6 |
|
|
2023
Q2 | $7.69M | Buy |
53,542
+47,229
| +748% | +$7.05M | 0.59% | 18 |
|
|
2023
Q1 | $1.3M | Buy |
+6,313
| New | +$1.07M | 0.14% | 144 |
|
|
2022
Q4 | – | Sell |
-17,611
| Closed | -$4.22M | – | 1909 |
|
|
2022
Q3 | $4.22M | Buy |
+17,611
| New | +$4.09M | 0.39% | 37 |
|
|
2022
Q2 | – | Sell |
-12,017
| Closed | -$4.22M | – | 1834 |
|
|
2022
Q1 | $4.22M | Sell |
12,017
-1,156
| -9% | -$453K | 0.31% | 23 |
|
|
2021
Q4 | $3.39M | Buy |
13,173
+1,705
| +15% | +$392K | 0.35% | 53 |
|
|
2021
Q3 | $2.44M | Buy |
11,468
+1,943
| +20% | +$413K | 0.22% | 65 |
|
|
2021
Q2 | $1.84M | Buy |
+9,525
| New | +$2.14M | 0.18% | 85 |
|
|
2021
Q1 | – | Sell |
-12,533
| Closed | -$3.17M | – | 1827 |
|
|
2020
Q4 | $3.17M | Buy |
+12,533
| New | +$4.78M | 0.34% | 57 |
|
|
2019
Q4 | $335K | Buy |
+135
| New | +$479K | 0.03% | 617 |
|
|
2019
Q3 | – | Sell |
-64
| Closed | -$232K | – | 1638 |
|
|
2019
Q2 | $232K | Sell |
64
-451
| -88% | -$1.9M | 0.01% | 942 |
|
|
2019
Q1 | $1.89M | Buy |
515
+375
| +268% | +$1.82M | 0.11% | 145 |
|
|
2018
Q4 | $1.2M | Sell |
140
-478
| -77% | -$3.51M | 0.06% | 232 |
|
|
2018
Q3 | $3.02M | Buy |
618
+314
| +103% | +$1.52M | 0.18% | 104 |
|
|
2018
Q2 | $1.58M | Buy |
304
+11
| +4% | +$66.7K | 0.09% | 233 |
|
|
2018
Q1 | $2.14M | Buy |
293
+166
| +131% | +$1.15M | 0.11% | 142 |
|
|
2017
Q4 | $1.17M | Buy |
127
+114
| +877% | +$1.14M | 0.06% | 373 |
|
|
2017
Q3 | $121K | Sell |
13
-187
| -94% | -$2.25M | 0.01% | 2022 |
|
|
2017
Q2 | $2.76M | Buy |
200
+112
| +127% | +$2.15M | 0.38% | 62 |
|
|
2017
Q1 | $1.84M | Buy |
88
+56
| +175% | +$1.38M | 0.19% | 86 |
|
|
2016
Q4 | $1.22M | Sell |
32
-24
| -43% | -$923K | 0.13% | 125 |
|
|
2016
Q3 | $1.94M | Buy |
+56
| New | +$2.62M | 0.33% | 71 |
|
|
2016
Q1 | – | Sell |
-9
| Closed | -$572K | – | 465 |
|
|
2015
Q4 | $572K | Sell |
9
-12
| -57% | -$917K | 0.08% | 209 |
|
|
2015
Q3 | $2.4M | Buy |
21
+9
| +75% | +$637K | 0.31% | 76 |
|
|
2015
Q2 | $755K | Buy |
+12
| New | +$857K | 0.07% | 166 |
|
Other funds holding LABD
JF
GS
IC
TSS
TRCT
Virtu Financial's LABD Position: Q4 2025 in Review
Virtu Financial sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2025, closing a stake of 15,837 shares — an estimated $640K sold.
Virtu Financial first reported a position in LABD in Q2 2015 and held it in 33 quarters. The position peaked at $13.3M in Q3 2023. 17 funds tracked by Wall St. Rank hold LABD as of Q4 2025.
- Virtu Financial reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2025 after selling out during the quarter.
- Virtu Financial sold 15,837 Direxion Daily S&P Biotech Bear 3X ETF shares in Q4 2025, an estimated $640K.
- Virtu Financial first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2015 and held it in 33 quarters.
- Virtu Financial's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $13.3M in Q3 2023.
- 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2025.
Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.